Business Wire

MAXON Adds New Dimension to Design with Cineware for Adobe Illustrator CC

Jaa

MAXON, the leading developer of the professional 3D modeling, animation, painting and rendering solution Cinema 4D, today announced the release of Cineware for Illustrator. This new plugin allows artists and designers to add and edit 3D objects directly within Adobe Illustrator CC, the industry-standard vector graphics application included in the Adobe Creative Cloud.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171010005917/en/

Cineware for Adobe Illustrator CC (Graphic: Business Wire)

Cineware for Adobe Illustrator CC (Graphic: Business Wire)

Cineware for Illustrator uses the same powerful 3D engine as Cinema 4D, MAXON’s industry-leading, intuitive, professional 3D application. Users can import any C4D file, and tweak the view, lighting and textures to integrate 3D elements with 2D designs or use 3D elements as templates when creating vector artwork in Illustrator CC. This enables designers to visualize product labels, incorporate rich 3D content into Illustrator compositions, or even arrange 3D elements as guides for form and perspective when creating vector artwork.

MAXON has partnered with TurboSquid, the leading online source for 3D models, to provide Cineware for Illustrator users a “jump start” into the third dimension with a collection of ready-to-use 3D models, including common product packaging and other 3D objects. Users of Cinema 4D can create and share their own custom 3D content for use in Illustrator CC.

Motion designers have enjoyed similar integration of Cinema 4D technology within Adobe After Effects CC since the introduction of the Cineware bridge in 2013. Cineware for Illustrator offers designers the ability to adjust object visibility, textures and lighting all from within Adobe Illustrator.

“Cinema 4D has long offered a fantastic, easy-to-learn toolset for product visualization and graphic design,” says Harald Egel, managing partner at MAXON Computer GmbH. “With Cineware for Illustrator we’re making both the Cinema 4D toolset and 3D in general more accessible to designers, and plan to develop this workflow even further in the future.”

Cineware for Illustrator Feature Highlights

  • 3D Objects: Rotate, position and show/hide individual 3D objects from any Cinema 4D scene, all within Illustrator CC.
  • Materials: Adjust the color, reflection, luminance, transparency, and bump directly within Illustrator CC. Users can even apply vector artwork to the surface of 3D models.
  • Cameras: Switch between pre-set cameras or use simple navigation tools to choose preferred viewing angle.
  • Lights: Enable or disable lights, and change their color to set a mood and emphasize shapes.
  • Integrate: Workflow allows easy removal of the background by choosing the automatically created alpha map so 3D elements can be integrated into existing vector artwork.

Availability

Cineware for Illustrator is available at no cost for macOS and Windows 10 on the MAXON Website.

Cineware for Illustrator CC at Adobe MAX and NAB East

MAXON Cineware for Illustrator will debut in the MAXON booth in the Community Pavilion at Adobe MAX (October 18-20, 2017 in Las Vegas) and NAB Show NY, Booth N264 (October 18-19, 2017 in New York).

Cinema 4D Upgrade Path

For Illustrator CC users that desire a rich, full-features 3D content creation experience, MAXON offers an attractive upgrade path to Cinema 4D.

Video footage about Cineware for Illustrator

Promotion-Video

Workflow-Video #1

Workflow-Video #2

About MAXON

Headquartered in Friedrichsdorf, Germany, MAXON Computer is a developer of professional 3D modeling, painting, animation and rendering solutions. Its award-winning Cinema 4D and BodyPaint 3D software products have been used extensively to help create everything from stunning visual effects in top feature films, TV shows and commercials, cutting-edge game cinematics for AAA games, as well for medical illustration, architectural and industrial design applications. MAXON has offices in Germany, USA, United Kingdom, Canada, France, Japan and Singapore. MAXON products are available directly from the web site and its worldwide distribution channel. MAXON is part of the Nemetschek Group.

Additional information on MAXON can be obtained as follows

Website

Cineversity

Facebook

Twitter

YouTube

LinkedIn

Google+

Instagram

All trademarks contained herein are the property of their respective owners.

Contact information

Media Contact
MAXON
US Internal:
press_us@maxon.net
or
US Media Contact:
Vicky Gray-Clark
Ambient Public Relations
408-243-8880
vicky@ambientpr.com
or
UK:
Liam Stacy
press_uk@maxon.net
or
Japan:
Toshihide Miyata
press_jp@maxon.net
or
France:
Eric Godey
press_fr@maxon.net
or
Singapore/ASEAN:
Vincent Ong
press_sg@maxon.net
or
Germany and all other countries:
Jessica Wege
press_de@maxon.net

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00Tiedote

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00Tiedote

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26Tiedote

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05Tiedote

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03Tiedote

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 11:00Tiedote

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme